(SYBX) –
-
Form 144 SYNLOGIC, INC. Filed by: Brennan Aoife
-
Form SC 13G SYNLOGIC, INC. Filed by: Radoff Bradley Louis
-
Form 4 SYNLOGIC, INC. For: Apr 02 Filed by: Dooley Mary Beth
-
Form 4 SYNLOGIC, INC. For: Apr 02 Filed by: Awad Antoine
-
Lineage Announces Appointment of Charlotte Hubbert, Ph.D., as Vice President of Corporate Development
-
Form 3 SYNLOGIC, INC. For: Mar 18 Filed by: Dooley Mary Beth
-
Form 4 SYNLOGIC, INC. For: Mar 19 Filed by: Flynn James P
-
Form 3 SYNLOGIC, INC. For: Mar 19 Filed by: Flynn James P
-
Form 8-K SYNLOGIC, INC. For: Mar 19
-
Form 144 SYNLOGIC, INC. Filed by: Brennan Aoife
-
H.C. Wainwright Upgrades Synlogic Inc. (SYBX) to Neutral (correction)
-
Synlogic (SYBX) Misses Q4 EPS by 171c
-
Form 10-K SYNLOGIC, INC. For: Dec 31
-
Synlogic Reports Fourth Quarter and Full Year 2023 Financial Results
-
Form 8-K SYNLOGIC, INC. For: Mar 19
-
Form 8-K SYNLOGIC, INC. For: Feb 17
-
Form 8-A12B SYNLOGIC, INC.
-
Form 8-K SYNLOGIC, INC. For: Feb 20
-
Synlogic (SYBX) Adopts Limited Duration Stockholders Rights Plan
-
Synlogic Adopts Limited Duration Stockholders Rights Plan
-
Form 3 SYNLOGIC, INC. For: Feb 09 Filed by: Funicular Funds, LP
-
Form SC 13D SYNLOGIC, INC. Filed by: Funicular Funds, LP
-
Form SC 13G SYNLOGIC, INC. Filed by: ARMISTICE CAPITAL, LLC
-
Form SC 13G/A SYNLOGIC, INC. Filed by: Kryzanowski John A
-
Form 8-K SYNLOGIC, INC. For: Feb 12
-
Synlogic (SYBX) plunges as it ceases operations following decision to discontinue Synpheny-3 study
-
Form SC 13G/A SYNLOGIC, INC. Filed by: FMR LLC
-
Chardan Downgrades Synlogic Inc. (SYBX) to Neutral 'on Early Termination of Synpheny-3 Trial'
-
H.C. Wainwright Double Downgrades Synlogic Inc. (SYBX) to Sell, 'Suffers a Sudden and Stunning Implosion'
-
Leerink Partners Downgrades Synlogic Inc. (SYBX) to Market Perform
-
Synlogic (SYBX) to Discontinue Synpheny-3 Study and Provides Corporate Update
-
Synlogic Announces Decision to Discontinue Synpheny-3 Study and Provides Corporate Update
-
Synlogic (SYBX) Halted, News Pending
-
Synlogic (SYBX) Announces Publication of Preclinical and Clinical Data for SYNB1353 as a Potential Treatment for Classical Homocystinuria
-
Synlogic Announces Publication of Preclinical and Clinical Data for SYNB1353 as a Potential Treatment for Classical Homocystinuria
-
Form 4 SYNLOGIC, INC. For: Jan 02 Filed by: Hurter Patricia N.
-
Form 4 SYNLOGIC, INC. For: Jan 02 Filed by: Barrett Peter
-
Synlogic (SYBX) Provides Corporate Update and Outlook for 2024
-
Synlogic Provides Corporate Update and Outlook for 2024
-
Form 8-K SYNLOGIC, INC. For: Dec 29
-
Synlogic (SYBX) Announces Contract with the Air Force Research Lab
-
Synlogic Announces Contract with the Air Force Research Lab
-
Alliance Global Partners Starts Synlogic Inc. (SYBX) at Buy
-
Synlogic Announces Abstract Accepted for Poster Presentation at the International Conference on Microbiome Engineering 2023
-
Form 8-K SYNLOGIC, INC. For: Nov 17
-
Form 8-K SYNLOGIC, INC. For: Nov 10
-
Form 4 SYNLOGIC, INC. For: Nov 10 Filed by: Brennan Aoife
-
Form 4 SYNLOGIC, INC. For: Nov 10 Filed by: Awad Antoine
-
Form 4 SYNLOGIC, INC. For: Nov 10 Filed by: JENSEN MICHAEL VANGSTED
-
Synlogic (SYBX) Tops Q3 EPS by 98c
Back to SYBX Stock Lookup